Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001085146-25-003253·Celldex Therapeutics, Inc.
Schedule 13G ownership disclosure
Celldex Therapeutics Inc
Common Stock, par value $0.001 · CUSIP: 15117B202
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Kynam Capital Management, LP
Shares: 6,500,000 · Class: 9.79%
- Kynam Capital Management GP, LLC
Shares: 6,500,000 · Class: 9.79%
- Yue Tang
Shares: 6,500,000 · Class: 9.79%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-003253
- Form type
- SCHEDULE 13G/A
- Filer
- Celldex Therapeutics, Inc.
- CIK
- CIK 744218
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership